These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 29663660)

  • 1. 7,12-Dimethylbenz[α]anthracene increases cell proliferation and invasion through induction of Wnt/β-catenin signaling and EMT process.
    Kwon YJ; Ye DJ; Baek HS; Chun YJ
    Environ Toxicol; 2018 Jul; 33(7):729-742. PubMed ID: 29663660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and EMT in cervical cancer.
    Cheng Z; Wang H; Yang Z; Li J; Chen X
    BMC Cancer; 2023 Nov; 23(1):1128. PubMed ID: 37986152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL and Celastrol Combinational Treatment Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells via Targeting Wnt/β-catenin Signaling Pathway.
    Qin JJ; Niu MD; Cha Z; Geng QH; Li YL; Ren CG; Molloy DP; Yu HR
    Chin J Integr Med; 2024 Apr; 30(4):322-329. PubMed ID: 37861963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.
    Su H; Jin X; Zhang X; Zhao L; Lin B; Li L; Fei Z; Shen L; Fang Y; Pan H; Xie C
    J Transl Med; 2015 Mar; 13():104. PubMed ID: 25888911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicerandrol C Suppresses Proliferation and Induces Apoptosis of HepG2 and Hela Cancer Cells by Inhibiting Wnt/β-Catenin Signaling Pathway.
    Zhou D; Chen D; Wu J; Feng T; Liu P; Xu J
    Mar Drugs; 2024 Jun; 22(6):. PubMed ID: 38921589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
    Wu Y; Tran T; Dwabe S; Sarkissyan M; Kim J; Nava M; Clayton S; Pietras R; Farias-Eisner R; Vadgama JV
    Breast Cancer Res Treat; 2017 Jun; 163(3):449-460. PubMed ID: 28337662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIEZO1 acts as a cancer suppressor by regulating the ROS/Wnt/β-catenin axis.
    Bo H; Wu Q; Zhu C; Zheng Y; Cheng G; Cui L
    Thorac Cancer; 2024 Apr; 15(12):1007-1016. PubMed ID: 38494915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoidan suppresses proliferation and epithelial-mesenchymal transition process via Wnt/β-catenin signalling in hemangioma.
    Zhu Z; Luo J; Li L; Wang D; Xu Q; Teng J; Zhou J; Sun L; Yu N; Zuo D
    Exp Dermatol; 2024 Mar; 33(3):e15027. PubMed ID: 38514926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese-12 acetate suppresses the migration, invasion, and epithelial-mesenchymal transition by inhibiting Wnt/β-catenin and PI3K/AKT signaling pathways in breast cancer cells.
    Ju H; Li Y; Xing X; Miao X; Feng Y; Ren Y; Qin J; Liu D; Chen Z; Yang Z
    Thorac Cancer; 2018 Mar; 9(3):353-359. PubMed ID: 29316252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt/β-catenin pathway in triple-negative breast cancer.
    Zhu Z; Li T; Wang H; Jiao L
    Mutat Res; 2024 Jun; 829():111868. PubMed ID: 38959561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression.
    Guturi KK; Sarkar M; Bhowmik A; Das N; Ghosh MK
    Breast Cancer Res; 2014 Dec; 16(6):496. PubMed ID: 25499975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal activation of the Wnt3a/β-catenin signaling pathway promotes the expression of T-box transcription factor 3(TBX3) and the epithelial-mesenchymal transition pathway to mediate the occurrence of adenomyosis.
    Li M; Li T; Jin T; Chen Y; Cheng L; Liang Q; Yan S; Li T; Ran Q; Chen W
    Mol Biol Rep; 2023 Dec; 50(12):9935-9950. PubMed ID: 37878207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin Promotes Expression of EMT-Related Transcription Factors and Invasion in a Src and FAK-Dependent Pathway in MCF10A Mammary Epithelial Cells.
    Olea-Flores M; Zuñiga-Eulogio M; Tacuba-Saavedra A; Bueno-Salgado M; Sánchez-Carvajal A; Vargas-Santiago Y; Mendoza-Catalán MA; Pérez Salazar E; García-Hernández A; Padilla-Benavides T; Navarro-Tito N
    Cells; 2019 Sep; 8(10):. PubMed ID: 31554180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde oxidase 1 promotes gallbladder carcinogenesis through ROS-mediated activation of the Wnt/β-catenin pathway.
    Yuan Z; Yi G; Ma R; Wang Z; Hu J; Zhao W; Hu Y
    Cell Signal; 2024 Apr; 116():111042. PubMed ID: 38199597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin-11 increases tumor cell proliferation and metastatic potential via Wnt pathway activation.
    Liu Y; Lei P; Samuel RZ; Kashyap AM; Groth T; Bshara W; Neelamegham S; Andreadis ST
    Mol Oncol; 2023 Oct; 17(10):2056-2073. PubMed ID: 37558205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
    Ahn SY
    BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASIC1a contributes to the epithelial-mesenchymal transformation of breast cancer by activating the Ca
    Wang J; Yang C; Yu R; Zhuang M; Jiang F
    Environ Toxicol; 2024 Feb; 39(2):991-1000. PubMed ID: 37994395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAT1 inhibits the proliferation and metastasis of cervical cancer cells by binding β-catenin.
    Chen M; Sun X; Wang Y; Ling K; Chen C; Cai X; Liang X; Liang Z
    Int J Clin Exp Pathol; 2019; 12(10):3807-3818. PubMed ID: 31933769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
    Kato Y; Fukazawa T; Tanimoto K; Kanawa M; Kojima M; Saeki I; Kurihara S; Touge R; Hirohashi N; Okada S; Hiyama E
    Cancer Sci; 2024 Mar; 115(3):847-858. PubMed ID: 38183173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro and In Vivo Evaluation of the Effectiveness and Safety of Amygdalin as a Cancer Therapy.
    El-Ela FIA; Gamal A; Elbanna HA; ElBanna AH; Salem HF; Tulbah AS
    Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.